Industry Reports
Bayer Second quarter of 2016: Bayer raises sales and earnings:
Group sales increase by 2.3 percent (Fx & portfolio adj.) to EUR 11,833 million / Pharmaceuticals continues strong growth trend / Consumer Health increases...
Industry Reports
Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics
Pfizer Inc announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene...
Packaging & Labelling
Bosch debuts jelly lab equipment in North America
At PACK EXPO International 2016, Bosch Packaging Technology will showcase its testing equipment for jelly production, including medicated and functional gummies, such as cough...
Production & Manufacturing
Alexion issued new FDA Form 483 for Rhode Island plant
The FDA has again raised issues at an Alexion plant that three years ago was issued a warning letter. The facility is where Alexion...
Press Releases
Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company
Biogen announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company that it expects to launch in early 2017. Bioverativ...
Clinical Trials
AstraZeneca Provides Update on Phase III Trial of Selumetinib in Non-Small Cell Lung Cancer
AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment in...
Clinical Trials
Antibe Therapeutics Announces Successful Phase 2 Trial Of ATB-346 In Osteoarthritis
Antibe Therapeutics Inc. is pleased to announce the successful completion of its phase 2 clinical trial of ATB-346 in osteoarthritis (“OA”). Twelve patients with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read